{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T15:30:25Z","timestamp":1768318225804,"version":"3.49.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"49","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,4]],"date-time":"2023-11-04T00:00:00Z","timestamp":1699056000000},"content-version":"vor","delay-in-days":3,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100013227","name":"Health Promotion Administration, Ministry of Health and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013227","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008903","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["A1090404"],"award-info":[{"award-number":["A1090404"]}],"id":[{"id":"10.13039\/100008903","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.vaccine.2023.11.010","type":"journal-article","created":{"date-parts":[[2023,11,10]],"date-time":"2023-11-10T02:02:13Z","timestamp":1699581733000},"page":"7444-7449","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Adverse events from HPV vaccination in Taiwan"],"prefix":"10.1016","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1828-9004","authenticated-orcid":false,"given":"Sz-An","family":"Tsai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5240-2808","authenticated-orcid":false,"given":"Chun-Yi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tzu-I","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3075-5853","authenticated-orcid":false,"given":"Shih-Pei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1007-3003","authenticated-orcid":false,"given":"Yong-Chen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2023.11.010_b0005","doi-asserted-by":"crossref","unstructured":"Human papillomavirus vaccines: WHO position paper, May 2017-Recommendations. Vaccine 2017;35:5753\u20135.","DOI":"10.1016\/j.vaccine.2017.05.069"},{"key":"10.1016\/j.vaccine.2023.11.010_b0010","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s40264-013-0039-5","article-title":"Safety of human papillomavirus vaccines: a review","volume":"36","author":"Macartney","year":"2013","journal-title":"Drug Saf"},{"key":"10.1016\/j.vaccine.2023.11.010_b0015","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s40264-017-0625-z","article-title":"Safety of human papillomavirus vaccines: an updated review","volume":"41","author":"Phillips","year":"2018","journal-title":"Drug Saf"},{"key":"10.1016\/j.vaccine.2023.11.010_b0020","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.vaccine.2023.11.010_b0025","unstructured":"PATH. Global HPV vaccine introduction overview; March 2022."},{"key":"10.1016\/j.vaccine.2023.11.010_b0030","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1080\/21645515.2016.1168952","article-title":"Quadrivalent HPV vaccine safety review and safety monitoring plans for nine-valent HPV vaccine in the United States","volume":"12","author":"Gee","year":"2016","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2023.11.010_b0035","first-page":"620","article-title":"Human papillomavirus vaccination coverage among adolescents, 2007\u20132013, and postlicensure vaccine safety monitoring, 2006\u20132014\u2013United States","volume":"63","author":"Stokley","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2023.11.010_b0040","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1097\/INF.0000000000000793","article-title":"An overview of quadrivalent human papillomavirus vaccine safety: 2006 to 2015","volume":"34","author":"Vichnin","year":"2015","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2023.11.010_b0045","doi-asserted-by":"crossref","first-page":"8279","DOI":"10.1016\/j.vaccine.2011.08.106","article-title":"Monitoring the safety of quadrivalent human papillomavirus vaccine: findings from the Vaccine Safety Datalink","volume":"29","author":"Gee","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.11.010_b0050","unstructured":"Committee to review adverse effects of V, Institute of M. In: Stratton K, Ford A, Rusch E, Clayton EW, editors. Adverse effects of vaccines: evidence and causality. Washington (DC): National Academies Press (US) Copyright 2012 by the National Academy of Sciences. All rights reserved; 2011."},{"key":"10.1016\/j.vaccine.2023.11.010_b0055","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1001\/archpediatrics.2012.1451","article-title":"Safety of quadrivalent human papillomavirus vaccine administered routinely to females","volume":"166","author":"Klein","year":"2012","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.vaccine.2023.11.010_b0060","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.bjid.2014.02.005","article-title":"Safety, tolerability and side effects of human papillomavirus vaccines: a systematic quantitative review","volume":"18","author":"Gon\u00e7alves","year":"2014","journal-title":"Braz J Infect Dis"},{"key":"10.1016\/j.vaccine.2023.11.010_b0065","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1001\/jama.2009.1201","article-title":"Postlicensure safety surveillance for quadrivalent human papillomavirus recombinant vaccine","volume":"302","author":"Slade","year":"2009","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.vaccine.2023.11.010_b0070","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1001\/jama.2014.2198","article-title":"Quadrivalent human papillomavirus vaccine and the risk of venous thromboembolism","volume":"312","author":"Scheller","year":"2014","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.vaccine.2023.11.010_b0075","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.f5906","article-title":"Autoimmune, neurological, and venous thromboembolic adverse events after immunisation of adolescent girls with quadrivalent human papillomavirus vaccine in Denmark and Sweden: cohort study","volume":"347","author":"Arnheim-Dahlstr\u00f6m","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2023.11.010_b0080","doi-asserted-by":"crossref","first-page":"4761","DOI":"10.1016\/j.vaccine.2017.06.030","article-title":"Human papillomavirus vaccination and risk of autoimmune diseases: a large cohort study of over 2 million young girls in France","volume":"35","author":"Miranda","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.11.010_b0085","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.vaccine.2010.09.020","article-title":"Guillain-Barr\u00e9 syndrome after Gardasil vaccination: data from Vaccine Adverse Event Reporting System 2006\u20132009","volume":"29","author":"Souayah","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.11.010_b0090","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.vaccine.2015.09.087","article-title":"Evaluation of the risk of venous thromboembolism after quadrivalent human papillomavirus vaccination among US females","volume":"34","author":"Yih","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.11.010_b0095","doi-asserted-by":"crossref","unstructured":"Ong SK, Abe SK, Thilagaratnam S, Haruyama R, Pathak R, Jayasekara H, et al. Towards elimination of cervical cancer; human papillomavirus (HPV) vaccination and cervical cancer screening in Asian National Cancer Centers Alliance (ANCCA) member countries. The Lancet Regional Health \u2013 Western Pacific. 2023;39.","DOI":"10.1016\/j.lanwpc.2023.100860"},{"key":"10.1016\/j.vaccine.2023.11.010_b0100","article-title":"Efficacy, immunogenicity and safety of HPV vaccination in Chinese population: a meta-analysis","volume":"11","author":"Guo","year":"2023","journal-title":"Front Public Health"},{"key":"10.1016\/j.vaccine.2023.11.010_b0105","article-title":"Association between human papillomavirus vaccination and serious adverse events in South Korean adolescent girls: nationwide cohort study","volume":"372","author":"Yoon","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2023.11.010_b0110","first-page":"265","article-title":"Immunogenicity and safety of human papillomavirus (HPV) vaccination in Asian populations from six countries: a meta-analysis","volume":"47","author":"Setiawan","year":"2017","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.vaccine.2023.11.010_b0115","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.jfma.2012.10.004","article-title":"A human papillomavirus public vaccination program in Taiwan: the Kinmen County experience","volume":"111","author":"Lee","year":"2012","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.vaccine.2023.11.010_b0120","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/j.jfma.2021.10.026","article-title":"Towards the elimination of cervical cancer in Taiwan","volume":"121","author":"Wu","year":"2022","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.vaccine.2023.11.010_b0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/21645515.2021.1986333","article-title":"Changing trends in HPV vaccination in Japan","volume":"18","author":"Ujiie","year":"2022","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2023.11.010_b0130","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1353\/hpu.2012.0007","article-title":"African American parents' HPV vaccination intent and concerns","volume":"23","author":"Sanders Thompson","year":"2012","journal-title":"J Health Care Poor Underserved"},{"key":"10.1016\/j.vaccine.2023.11.010_b0135","doi-asserted-by":"crossref","first-page":"263","DOI":"10.3109\/03009734.2013.809039","article-title":"Trust versus concerns\u2014how parents reason when they accept HPV vaccination for their young daughter","volume":"118","author":"Gottvall","year":"2013","journal-title":"Ups J Med Sci"},{"key":"10.1016\/j.vaccine.2023.11.010_b0140","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jadohealth.2006.10.007","article-title":"Acceptance of human papillomavirus vaccination among Californian parents of daughters: a representative statewide analysis","volume":"40","author":"Constantine","year":"2007","journal-title":"J Adolesc Health"},{"key":"10.1016\/j.vaccine.2023.11.010_b0145","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1007\/s10995-012-1066-z","article-title":"A national study of HPV vaccination of adolescent girls: rates, predictors, and reasons for non-vaccination","volume":"17","author":"Kester","year":"2013","journal-title":"Matern Child Health J"},{"key":"10.1016\/j.vaccine.2023.11.010_b0150","doi-asserted-by":"crossref","unstructured":"Sonawane K, Lin Y-Y, Damgacioglu H, Zhu Y, Fernandez ME, Montealegre JR, et al. Trends in human papillomavirus vaccine safety concerns and adverse event reporting in the United States. JAMA Netw Open 2021;4:e2124502.","DOI":"10.1001\/jamanetworkopen.2021.24502"},{"key":"10.1016\/j.vaccine.2023.11.010_b0155","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.2147\/IDR.S178381","article-title":"Recombinant human papillomavirus nonavalent vaccine in the prevention of cancers caused by human papillomavirus","volume":"12","author":"Toh","year":"2019","journal-title":"Infect Drug Resist"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2301321X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2301321X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:33:06Z","timestamp":1759404786000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X2301321X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":31,"journal-issue":{"issue":"49","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S0264410X2301321X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.11.010","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adverse events from HPV vaccination in Taiwan","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.11.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}